Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


15.07.2019

1 Clin Infect Dis
1 Dig Dis Sci
3 J Hepatol
1 J Infect Dis
2 J Med Virol
4 J Viral Hepat
2 J Virol
1 Lancet Gastroenterol Hepatol
4 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. ARTENIE AA, Cunningham EB, Dore GJ, Conway B, et al
    Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international s
    Clin Infect Dis. 2019 Jul 11. pii: 5531892. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. MAK LY, Liu SH, Yap DY, Seto WK, et al
    In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue.
    Dig Dis Sci. 2019 Jul 6. pii: 10.1007/s10620-019-05717.
    PubMed     Text format     Abstract available


    J Hepatol

  3. LEI Z, Xia Y, Si A, Wang K, et al
    Antiviral Therapy Improves Survival in patients with HBV infection and Intrahepatic Cholangiocarcinoma undergoing Liver Resection.
    J Hepatol. 2017 Nov 16. pii: S0168-8278(17)32438.
    PubMed     Text format     Abstract available

  4. AREGAY A, Sekyere SO, Deterding K, Port K, et al
    Elimination of Hepatitis C Virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
    J Hepatol. 2019 Jul 8. pii: S0168-8278(19)30397.
    PubMed     Text format     Abstract available

  5. COMARMOND C, Lorin V, Marques C, Maciejewski-Duval A, et al
    TLR9 Signaling in HCV-Associated Atypical Memory B Cells Triggers Th1 and Rheumatoid Factor Autoantibody Responses.
    J Hepatol. 2019 Jul 4. pii: S0168-8278(19)30401.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. MARTIN NK, Jansen K, An der Heiden M, Boesecke C, et al
    Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis.
    J Infect Dis. 2019 Jul 12. pii: 5532024. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  7. IMAI S, Yamana H, Inoue N, Akazawa M, et al
    Validity of administrative database detection of previously-resolved hepatitis B virus in Japan.
    J Med Virol. 2019 Jul 8. doi: 10.1002/jmv.25540.
    PubMed     Text format     Abstract available

  8. MODIYINJI AF, Atsama MA, Monamele CG, Nola M, et al
    Seroprevalence of Hepatitis E virus antibodies in different human populations of Cameroon.
    J Med Virol. 2019 Jul 12. doi: 10.1002/jmv.25545.
    PubMed     Text format     Abstract available


    J Viral Hepat

  9. READ P, Gilliver R, Kearley J, Lothian R, et al
    Treatment Adherence and Support for People who Inject Drugs Taking Direct Acting Antiviral Therapy for Hepatitis C Infection.
    J Viral Hepat. 2019 Jul 12. doi: 10.1111/jvh.13175.
    PubMed     Text format     Abstract available

  10. DESHPANDE R, Stepanova M, Golabi P, Brown K, et al
    Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Hemodialysis units.
    J Viral Hepat. 2019 Jul 11. doi: 10.1111/jvh.13173.
    PubMed     Text format     Abstract available

  11. IKEDA H, Watanabe T, Atsukawa M, Toyoda H, et al
    Evaluation of 8-Week Glecaprevir/Pibrentasvir Treatment in Direct-acting Antiviral -naive Non-cirrhotic Genotype 1 and 2 HCV Patients in a Real-world Setting in Japan.
    J Viral Hepat. 2019 Jul 6. doi: 10.1111/jvh.13170.
    PubMed     Text format     Abstract available

  12. WU J, Guo N, Zhang X, Xiong C, et al
    HEV-LFS : a novel scoring model for patients with hepatitis E virus-related liver failure.
    J Viral Hepat. 2019 Jul 11. doi: 10.1111/jvh.13174.
    PubMed     Text format     Abstract available


    J Virol

  13. MEKONNEN ZA, Grubor-Bauk B, English K, Leung P, et al
    Single dose vaccination with a hepatotropic Adeno-associated virus (AAV) efficiently localises T cell immunity in the liver with the potential to confer rapid protection against hepatitis C virus (HCV).
    J Virol. 2019 Jul 10. pii: JVI.00202-19. doi: 10.1128/JVI.00202.
    PubMed     Text format     Abstract available

  14. WOLFISBERG R, Holmbeck K, Nielsen L, Kapoor A, et al
    Replicons of a rodent hepatitis C model virus permit selection of highly permissive cells.
    J Virol. 2019 Jul 10. pii: JVI.00733-19. doi: 10.1128/JVI.00733.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  15. POURKARIM MR, Thijssen M, Alavian SM, Van Ranst M, et al
    Natural disasters pose a challenge for hepatitis elimination in Iran.
    Lancet Gastroenterol Hepatol. 2019;4:581-582.
    PubMed     Text format    


    PLoS One

  16. CAMMAROTA S, Citarella A, Guida A, Conti V, et al
    The inpatient hospital burden of comorbidities in HCV-infected patients: A population-based study in two Italian regions with high HCV endemicity (The BaCH study).
    PLoS One. 2019;14:e0219396.
    PubMed     Text format     Abstract available

  17. KATO K, Shimada N, Atsukawa M, Abe H, et al
    Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C.
    PLoS One. 2019;14:e0219022.
    PubMed     Text format     Abstract available

  18. CALNER P, Sperring H, Ruiz-Mercado G, Miller NS, et al
    HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center.
    PLoS One. 2019;14:e0218388.
    PubMed     Text format     Abstract available

  19. LAWANDI A, Cheng MP, Lee TC
    Hepatitis B testing practices at a tertiary care centre and their associated costs: A retrospective analysis.
    PLoS One. 2019;14:e0219347.
    PubMed     Text format     Abstract available


    Vaccine

  20. ORK V, Woodring J, Shafiqul Hossain M, Wasley A, et al
    Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Vaccine. 2019 Jul 5. pii: S0264-410X(19)30850.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: